Elevance Health, Inc. reported revenue of $50.47B for the period ended 2026-06-30, +1.4% year on year. Net income was $1.46B, a 2.9% net margin on a 89.1% gross margin. Free cash flow for the period was $1.63B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $50.47B | +1.4% |
| Gross profit | $44.98B | — |
| Operating income | $1.76B | — |
| Net income | $1.46B | -16.1% |
| Gross margin | 89.1% | Net margin 2.9% |
| Revenue Q/Q | +0.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $5.49B | 10.9% |
| SG&A | $5.55B | 11.0% |
| Tax & other | $0.30B | 0.6% |
| Item | Amount |
|---|---|
| Total assets | $126.44B |
| Total liabilities | $81.42B |
| Shareholders' equity | $45.02B |
| Equity / assets | 35.6% |
| Operating cash flow | $1.91B |
| Capital expenditure | $0.29B |
| Free cash flow | $1.63B |
| Cash conversion (OCF / net income) | 131% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
EME ・ EMR ・ ETR ・ EOG ・ EQT ・ EFX ・ EQIX ・ EQR ・ ERIE ・ ESS ・ EL ・ EG
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies